The bill HB123 aims to extend the operations of the Alabama State Board of Pharmacy until October 1, 2026, while implementing significant changes to its structure and authority. Key amendments include expanding the board's membership from five to nine members, with new appointments for various pharmacy professionals and a registered pharmacy technician. The bill also clarifies the qualifications and duties of state drug investigators, enhances the board's authority to impose penalties, and updates provisions related to the general counsel. Specific insertions include requirements for practitioners to indicate whether a brand name drug is to be dispensed and the establishment of a penalty schedule for violations, which must be published by January 1, 2026.

Additionally, the bill modifies the renewal process for pharmacy permits, streamlining application requirements and establishing a late fee structure. It removes previous stipulations regarding the board's membership qualifications, allowing for a more diverse representation. The bill mandates that all pharmacies register biennially and clarifies the board's authority to revoke or suspend licenses for violations. It also requires the board to submit annual reports on its financial activities and licensed registrants. Overall, HB123 seeks to enhance regulatory oversight and ensure compliance within the pharmacy sector while promoting inclusivity and operational efficiency within the board.

Statutes affected:
Introduced: 34-23-3, 34-23-8, 34-23-12, 34-23-13, 34-23-30, 34-23-32, 34-23-33, 34-23-34, 34-23-52, 34-23-90, 34-23-91, 34-23-92, 34-23-93, 34-23-131
Engrossed: 34-23-3, 34-23-8, 34-23-12, 34-23-13, 34-23-30, 34-23-32, 34-23-33, 34-23-34, 34-23-52, 34-23-90, 34-23-91, 34-23-92, 34-23-93, 34-23-131
Enrolled: 34-23-3, 34-23-8, 34-23-12, 34-23-13, 34-23-30, 34-23-32, 34-23-33, 34-23-34, 34-23-52, 34-23-90, 34-23-91, 34-23-92, 34-23-93, 34-23-131